• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

叶状乳腺肿瘤与三种类固醇激素受体

Phylloid breast tumors and three steroid hormone receptors.

作者信息

Lang B A, Vermousek I, Simicková M, Cernoch M, Nekulová M, Paćovský Z, Rejthar A

机构信息

Masaryk Memorial Cancer Institute, Brno, Czeck Republic.

出版信息

Neoplasma. 1997;44(1):53-7.

PMID:9201281
Abstract

The concentrations of three steroid hormones (estrogen, progesteron and 1,25-dihydroxycholecalciferol) receptors (ER, PgR, DR) in tissue cytosol were analyzed in a group of 17 breast phylloid tumors. Comparison with breast carcinoma tissue samples (n = 37) did not reveal significant differences in average values of ER, PgR, and DR. Comparison with another control set of 30 samples of dysplastic tissue of the mammary gland showed significant differences only in PgR values. Only 18% of phylloid tumor samples contained levels above cut-of-line of all three receptors (ER, PgR, DR-5,10,10 resp. fmol/ mg protein). The most frequent combination was ER+PgR+DR-(41%). As far as we know, DR in phylloid breast tumors have never been examined before. In approximately 60% of our samples we found the expression of DR, in 36% the estimated values were above 10 fmol/mg protein. Cells of the tissue not expressing DR seem to belong to a special phenotype. We found no ER+PgR- or ER-PgR-combinations in them. The group which expresses DR is characterized by a higher dispersion of PgR values.

摘要

对一组17例乳腺叶状肿瘤的组织胞浆中三种甾体激素(雌激素、孕酮和1,25 - 二羟胆钙化醇)受体(ER、PgR、DR)的浓度进行了分析。与乳腺癌组织样本(n = 37)比较,未发现ER、PgR和DR的平均值有显著差异。与另一组30例乳腺发育异常组织样本比较,仅在PgR值上有显著差异。仅18%的叶状肿瘤样本中所有三种受体(ER、PgR、DR分别为5、10、10 fmol/mg蛋白)水平高于临界值。最常见的组合是ER+PgR+DR-(41%)。据我们所知,此前从未对乳腺叶状肿瘤中的DR进行过检测。在我们大约60%的样本中发现了DR的表达,36%的估计值高于10 fmol/mg蛋白。组织中不表达DR的细胞似乎属于一种特殊的表型。在它们当中我们未发现ER+PgR-或ER-PgR-的组合。表达DR的组的特征是PgR值的离散度较高。

相似文献

1
Phylloid breast tumors and three steroid hormone receptors.叶状乳腺肿瘤与三种类固醇激素受体
Neoplasma. 1997;44(1):53-7.
2
Changing estrogen and progesterone receptor patterns in breast carcinoma during the menstrual cycle and menopause.月经周期及绝经期间乳腺癌中雌激素和孕激素受体模式的变化
Cancer. 1998 Aug 15;83(4):698-705.
3
Hormone receptors and Japanese breast cancer.
Acta Pathol Jpn. 1982;32 Suppl 1:145-54.
4
Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.乳腺导管癌中雌激素受体、孕激素受体及c-erbB2癌基因蛋白表达的改变
Cell Biol Int. 2008 Jun;32(6):698-707. doi: 10.1016/j.cellbi.2008.01.007. Epub 2008 Jan 25.
5
Lack of relationship between the levels of prolactin receptors and steroid receptors in women with breast cancer.
Biomed Pharmacother. 1988;42(5):327-34.
6
Lymphocyte reactivity to mitogens and tumor sex steroid receptors in breast cancer patients.乳腺癌患者淋巴细胞对丝裂原的反应性及肿瘤性类固醇受体
Biomed Pharmacother. 1985;39(8):442-4.
7
[Expression of steroid receptors and DNA synthesis in male breast cancer].[男性乳腺癌中类固醇受体的表达与DNA合成]
Pathologica. 2003 Feb;95(1):31-6.
8
Quantitative oestrogen and progesterone receptor values in primary breast cancer and predictability of response to endocrine therapy.原发性乳腺癌中雌激素和孕激素受体的定量值及内分泌治疗反应的可预测性
Clin Oncol. 1983 Sep;9(3):245-50.
9
Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.重新评估辅助性乳腺癌试验:通过免疫组化法与提取法评估激素受体状态。
J Natl Cancer Inst. 2006 Nov 1;98(21):1571-81. doi: 10.1093/jnci/djj415.
10
[Dna synthesis and expression of steroid receptors in cells of human breast carcinoma].[人乳腺癌细胞中类固醇受体的DNA合成与表达]
Pathologica. 1996 Apr;88(2):111-6.